U.S. Water Utilities Stock News

NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Denali Therapeutics (DNLI) Stock Looks Stretched On Fair Value Yet Reasonable On Book Value

Denali Therapeutics has delivered a strong 1 year rebound for shareholders, yet multiple valuation checks suggest the current share price sits above where an intrinsic value estimate and market based comparisons would place it. The stock therefore looks priced for meaningful execution on its drug pipeline even after a difficult 5 year stretch. Over 5 years, Denali Therapeutics shareholders have seen the investment fall about 60%, which hints that earlier optimism has not yet translated into...
NasdaqGS:CG
NasdaqGS:CGCapital Markets

Is Carlyle Group (CG) Cheap Following Exiger's AI Platform Launch?

Carlyle Group (CG) is back in focus after portfolio company Exiger rolled out its AI native 1Exiger platform, following a US$1.2b investment round that involved Carlyle and other backers. Despite Exiger’s AI push grabbing headlines, Carlyle Group’s recent share price performance has been weak. The stock is down 12.29% over 30 days and 30.43% year to date, while a 3-year total shareholder return of 38.05% shows a more constructive longer-term record. Scan other private markets and AI exposed...
NYSE:CLX
NYSE:CLXHousehold Products

Clorox (CLX) Slides Into The Valuation Spotlight, Is The Stock 14% Undervalued?

Clorox (CLX) has come under pressure recently, with the share price down 17% over the past month and 9% in the past 3 months. This has put the consumer staples group back under the microscope for investors. Zooming out, Clorox’s 1-year total shareholder return is down 25.63%, and the 3-year and 5-year total shareholder returns are also lower. This suggests that recent weakness in the share price is part of a longer period of fading momentum around the stock. Compare Clorox’s recent slide with...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly (FSLY) Stock Could Be Above Fair Value On Growth Hopes

Fastly stock has almost tripled over the past year, yet the broader valuation checks suggest the current share price leans expensive rather than offering clear value. The 199.6% return over the past 12 months highlights how quickly expectations around Fastly have shifted and raises the bar for what needs to go right next. Expectations for continued adoption of Fastly's edge computing and content delivery services can support a higher valuation. However, any setback in turning that usage into...
NYSE:APAM
NYSE:APAMCapital Markets

Is Artisan Partners Asset Management (APAM) Stock A Bargain Or Fully Priced?

Artisan Partners Asset Management stock has fallen over recent months, yet several valuation checks suggest the shares may be pricing in more caution than the business fundamentals imply. After a three year gain of 30.7%, the recent pullback leaves investors weighing a cheaper entry point against the usual uncertainties around future fee income and fund flows. Over the past 3 years, Artisan Partners Asset Management has returned 30.7%, which points to meaningfully positive longer term...
NYSE:LUV
NYSE:LUVAirlines

Southwest Airlines (LUV) Could Be 24% Undervalued As Seating Changes Come Into View

Southwest Airlines (LUV) has drawn investor attention after recent share price weakness, with the stock down about 13% over the past month and roughly 14% over the past 3 months. The recent 12.8% 1 month and 13.7% 3 month share price declines suggest momentum for Southwest Airlines is fading in the short term, even though the 1 year total shareholder return of 26.2% and 3 year total shareholder return of 40.9% still point to a stronger longer run record. Scan for other airline and travel...
NYSE:FBIN
NYSE:FBINBuilding

Fortune Brands (FBIN) Appoints Peter G. Clifford As CFO And Executive Vice President

Fortune Brands Innovations (NYSE:FBIN) appointed Peter G. Clifford as Chief Financial Officer and Executive Vice President, effective September 21, 2026. Clifford brings more than 30 years of finance and operational leadership across building products and healthcare businesses. His background includes experience in finance transformation, global operations and M&A activity at publicly traded companies. The appointment of Peter G. Clifford as CFO and Executive Vice President is important...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics (TXG) Stock Looks Expensive Despite Fresh AI Pathology Optimism

10x Genomics has delivered a very strong 1 year gain while the broader valuation checks still flag the stock as expensive rather than a clear bargain. The share price return over the past 12 months is 442.6%, which puts 10x Genomics among the more extreme recent movers in the market and raises the bar for what needs to go right next. The newly announced collaboration with Lunit on AI enabled pathology analysis can support optimism around long term demand, while execution risk in scaling the...
NYSE:PINS
NYSE:PINSInteractive Media and Services

Will AI Shopping Push Change Pinterest (PINS) Stock Narrative

Pinterest has reported that it now serves more than 640 million users and is positioning itself as an AI-driven shopping assistant, with over two thirds of revenue tied to lower funnel performance advertising and around 30% of that processed through its Performance+ platform. The acquisition of tvScientific moves Pinterest into connected TV advertising, which broadens monetization channels while the group still contends with European regulation and a reworked international sales...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Applied Materials (AMAT) Stock May Be A Bargain On Earnings But Full On Broader Checks

Applied Materials stock has delivered very strong gains over the last three years, yet the current valuation picture sends mixed signals. Investors see a powerful multiyear return profile set against a broader checkup that does not clearly label the shares as either cheap or stretched. For anyone looking at Applied Materials today, the key question is whether the recent pullback meaningfully improves the entry point or simply trims some heat off a still fully valued story. Over the last 3...
NYSE:WK
NYSE:WKSoftware

Workiva (WK) Stock Looks Fully Valued After A 53% Five Year Fall

Workiva has seen its share price fall over the longer term, yet the stock still screens as relatively expensive on market multiples. This leaves investors weighing whether the current level fairly reflects its prospects. With a mixed value score and a long stretch of negative returns, the question is how much optimism is already baked into Workiva’s valuation today. Workiva shares have declined 53.4% over 5 years, which suggests long term holders have absorbed significant capital pressure...
NYSE:OSK
NYSE:OSKMachinery

Oshkosh (OSK) Stock Looks Undervalued On Cash Flow And Earnings

Oshkosh stock has delivered a 56.1% gain over the past three years, yet current valuation checks suggest the shares still trade at a discount to what the underlying cash flows imply. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside compared with the recent US$145.85 close, and market multiple checks tell a similar story. A 56.1% return over three years points to a business that has rewarded patient holders, while the latest move still leaves room for...
NYSE:MATX
NYSE:MATXShipping

Is Matson (MATX) Still Undervalued Following Its Recent Run?

Matson stock reaction puts recent gains under the microscope Fresh research attention on Matson (MATX), including a top Zacks Rank and strong broker sentiment, has pushed the stock further into the spotlight after a solid multi month price run. At a share price of $230.18, Matson has seen strong short term momentum, with a 30 day share price return of 7.33% and a year to date share price return of 86.06%. The 1 year total shareholder return of 124.82% highlights how powerful this move has...
NasdaqGS:UBSI
NasdaqGS:UBSIBanks

United Bankshares (UBSI) Stock Looks Cheap On Fair Value But Pricey On Earnings

United Bankshares has delivered strong share price gains over the past few years, yet the valuation checks send a mixed message, with an Excess Returns intrinsic value estimate pointing to upside while earnings based multiples lean the other way. For investors, the puzzle is whether the current US$47.22 price still leaves enough breathing room if expectations cool. Over the past 3 years, United Bankshares has returned about 88.9%, which puts extra focus on whether the current level already...
NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy (NRG) Stock May Be Fairly Valued As Earnings Hold Up

NRG Energy has delivered a powerful run over the past five years, yet the stock is now coming off a sharp pullback and the broader valuation checks suggest pricing that looks neither clearly cheap nor clearly expensive. NRG Energy has returned about 207.5% over five years, which puts long term holders in a strong position even though more recent returns have cooled. The business can see its valuation influenced by how reliably it converts cash from its power portfolio, while any hit to cash...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Is Rebranding As Modexus Solutions After A Sweeping Overhaul

Modine Manufacturing (NYSE:MOD) plans to rebrand as Modexus Solutions following a major reshaping of the business. The company is spinning off its Performance Technologies unit into a separate entity as part of the overhaul. Modine will combine its remaining operations with Gentherm through a merger, creating a broader thermal management platform. This rebrand to Modexus Solutions after the Gentherm merger and Performance Technologies spinoff is a key shift to weigh carefully. Our analysis...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

What Should WD-40 (WDFC) Investors Know About Its New CFO And Restructure?

WD-40 (NasdaqGS:WDFC) has appointed Keith Stauffer as Chief Financial Officer, effective November 2, 2026. Current CFO Sara K. Hyzer is set to move into the role of Division President, Americas, on the same date. The company is restructuring internal divisions, with the CFO transition aligning executive oversight with the revised Americas unit. The CFO handover to Keith Stauffer and Sara K. Hyzer's new Americas role comes against broader shifts our research tracks. We have also flagged 3...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Ardelyx (ARDX) Could Be 72% Undervalued Following Its September Investor Conference Run

Ardelyx (ARDX) is heading into a busy week with back to back investor appearances, including Citigroup’s Biopharma Back to School Summit on September 9 and Cantor Fitzgerald’s Global Healthcare Conference on September 10. Against this backdrop of conferences, Ardelyx’s recent trading has been weak. The share price is at $3.58 after declining 9.82% over the past 30 days and 37.08% over 90 days, while the 1-year total shareholder return is down 45.84%, compared with a 5-year total shareholder...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

JD.com (JD) Looks Fully Valued As Joybuy Deal Puts Fresh Focus On Valuation

Zendure’s new partnership with Joybuy, JD.com (NasdaqGS:JD)’s cross border platform, puts an AI powered SolarFlow 2400 AC home storage bundle in front of German shoppers with rapid delivery and customer support. For JD.com, the Joybuy tie up lands at a time when momentum has been soft, with the latest 30 day share price return down 7.65% and the 1 year total shareholder return declining 16.83% despite periodic one day moves such as the recent 0.15% gain at a US$27.06 share price. Scan how...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Has Euronet Worldwide (EEFT) Fallen Far Enough to Look Cheap?

Euronet Worldwide stock has had a tough five years, yet current valuation checks suggest the shares may now trade at a meaningful discount to an intrinsic value estimate built from the business’s own economics. For investors, that contrast between a weak share chart and a cheaper looking appraisal is where the story starts. Over the past 5 years, Euronet Worldwide shareholders have seen the price decline about 43%, which sets expectations low and makes any valuation gap more...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital (GEN) Stock May Be 39% Undervalued On Avast Zero Day News

Gen Digital has delivered a strong 68.5% gain over the past three years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples still point to an undervalued stock. The current share price of US$30.26 trades at a meaningful discount to that intrinsic value estimate, even after this solid multi year run. Over the past 3 years, Gen Digital has returned 68.5%, which puts recent pricing on investors' radar after a sustained move higher. Future cash flow...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Karooooo (KARO) Could Be 12% Undervalued As Recurring Revenue Momentum Draws Attention

Karooooo (KARO) is drawing fresh attention as investors weigh its recurring subscription revenue, steady subscriber additions, and global rollout supported by infrastructure spending in Southeast Asia and Europe, along with a focus on cash generation and returns. Recent trading has been strong, with the share price at US$64.78 and a 90-day share price return of 37.04% alongside a year-to-date gain of 45.02%. The 3-year total shareholder return of 191.28% shows how long-term holders in...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

Is BioCryst Pharmaceuticals (BCRX) Undervalued After Its Recent Share Price Slide?

BioCryst Pharmaceuticals (BCRX) has drawn fresh attention after recent share weakness, with the price closing at US$8.12. The move comes alongside mixed return figures over the past year and over a multi year period. For BioCryst Pharmaceuticals, the recent 7 day share price decline of 18.47% and 30 day fall of 23.32% sit against a positive year to date share price return of 8.27% and a 3 year total shareholder return of 18.54%. This suggests that momentum has cooled after a stronger multi...
NYSE:RXO
NYSE:RXOTransportation

RXO (RXO) Stock Looks Fairly Valued After Its 52% Rally

RXO stock has delivered a strong 51.8% gain year to date, yet current valuation checks suggest the shares are closer to fairly priced than obviously cheap, with some metrics even hinting at upside. The Discounted Cash Flow (DCF) intrinsic value estimate sits almost in line with the market, while earnings based multiples suggest the stock may still be undervalued. Year to date, RXO is up 51.8%, which puts extra focus on whether recent enthusiasm has already been reflected in the share...